Impact of Complex Apoptotic Signaling Pathways on Cancer Cell Sensitivity to Therapy

Area of Science:

• Oncology
• Molecular Biology
• Cell Death Signaling

Background:

• Anticancer drugs induce diverse cell death mechanisms, including apoptosis and non-apoptotic pathways.
• Signaling pathways for drug-induced apoptosis vary between sensitive and resistant cancer cells.
• The c-Jun/AP-1/p53 pathway is altered in multidrug-resistant leukemia, affecting apoptotic cell death.

Purpose of the Study:

• To review signaling pathways involved in anticancer drug-induced cell death.
• To discuss alterations in these pathways in drug-resistant cancer cells.
• To explore strategies for enhancing anticancer drug efficacy by modulating cell death pathways.

Main Methods:

• Review of existing literature on anticancer drug-induced cell death.
• Analysis of signaling pathways including c-Jun/AP-1, p53, Gadd153, and caspase cascades.
• Examination of the roles of intrinsic and extrinsic apoptotic pathways.
• Investigation of antiapoptotic genes (e.g., Bcl-2) and their modulation.

Main Results:

• Anticancer drugs induce apoptosis via c-Jun/AP-1 and Gadd153 pathways, irrespective of p53 status.
• Gadd153 induction involves mitochondrial permeabilization and endoplasmic reticulum stress.
• Apoptosis induction utilizes intrinsic (cytochrome c) and extrinsic pathways, involving caspase-dependent and -independent mechanisms.
• Targeting antiapoptotic genes like Bcl-2 and modulating Bcl-xS enhances drug sensitivity in resistant cells.

Conclusions:

• Anticancer drug efficacy can be improved by targeting specific cell death signaling pathways.
• Modulating apoptosis, particularly through antiapoptotic genes, offers a promising strategy against drug resistance.
• Further research is needed to elucidate the role of autophagy in cancer therapy.